From Our Thought Leader's

MoleculeAI's Quest: Revolutionizing Drug Discovery with Artificial Intelligence

In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering the integration of artificial intelligence and molecular science to transform drug discovery. Sa... Read more

11 September, 2023 | Monday | Interaction
CEO Dr. Albert Bourla Highlights Pfizer's Remarkable Progress in Product Launches and Milestones in 2023

Second-Quarter 2023 Revenues of $12.7 Billion    Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 53% Operational Decrease in Second- Quarter 2023 Revenues Second-Quarter 2023 Revenues from Comirnaty(1... Read more

04 September, 2023 | Monday | Company results
Avantor CEO Michael Stubblefield Commends Utilization of Avantor Business System to Navigate Tough Market Trends, Expresses Confidence in Long-Term Growth

  "While market trends during the quarter, especially in biopharma, were more challenging than anticipated, we leveraged the Avantor Business System to drive productivity and control costs, enabling us to deliver adjusted EBITDA margin, earning... Read more

29 August, 2023 | Tuesday | Company results
Bayer President, Sebastian Guth, Highlights Alarming Link: Rising Fear, Lack of Education, and Distrust Hinder Access to Vital Preventative Care

One in Four American Adults Would Rather Not Know They Have Cancer   A new study from The Harris Poll, commissioned by Bayer, suggests fear factors have an impact on diagnoses and preventative care – one in four American adults would rat... Read more

22 August, 2023 | Tuesday | Analysis

Bio Finance

Qihan Biotech Completes Pre-Series B Financing for Stem Cell-Derived Cell Therapy in China

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation,  announced the successful completion of a pre-Ser... Read more

25 September, 2023 | Monday | News
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker

-Brain diagnostics innovator BrainScope announced  a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B equity financing round. This investment supports the ongoing development of a ... Read more

20 September, 2023 | Wednesday | News

Contract Services

Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company’s Millipore® CTDMO Services now encompass all key stages of mRNA technologies, lipids... Read more

27 September, 2023 | Wednesday | News
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

Charles River Laboratories International, Inc.  announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The platform has the capability to reduce LVV manufacturing timelines for gene and gene-modified cell... Read more

27 September, 2023 | Wednesday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in